Innoscripta (1INN) Q3 2025 earnings summary

Executive summary

• Achieved strong topline growth in Q3 2025 and for the nine months ended September 30, 2025, with revenue increasing to €70.7 million from €39.2 million year-over-year.

• Operational efficiency improvements led to higher profitability and enhanced scalability.

• Consolidated net income for the period rose to €27.88 million, up from €14.04 million in the prior year period.

• Subscribed capital doubled to €10 million, and a €24 million dividend was paid during the period.

• Business remains on track for further growth, supported by robust EBIT margins.

Financial highlights

• Q3 2025 adjusted revenue reached €39.5m, up 48.6% year-over-year from €26.6m in Q3 2024.

• Revenues grew by 80% year-over-year for the nine-month period, reaching €70.7 million.

• Q3 2025 EBIT was €16.7m, with an EBIT margin of 41.5%.

• Cash and cash equivalents at period end were €38.86 million, up from €16.86 million a year earlier.

• Free cash flow for Q3 2025 was €33.4m, driven by profitability and disciplined capital expenditure.

Outlook and guidance

• Management expects continued growth, leveraging operational efficiencies and scalability.

• No explicit forward-looking statements or guidance provided, but strong revenue and profit growth indicate positive momentum.

• Forward-looking statements are subject to risks related to economic, political, and SaaS industry conditions.